Misaligned Urgency: Why Status Exceptions May Be Paradoxically Lowering Priority for the Sickest Children in Heart Transplantation

The Paradox of Priority: Rethinking Status Exceptions in Pediatric Heart Transplantation

In the high-stakes environment of pediatric heart transplantation, the scarcity of donor organs creates a constant tension between clinical urgency and equitable allocation. The United States heart allocation system, managed by the Organ Procurement and Transplantation Network (OPTN), is designed to prioritize the sickest patients—those at the highest risk of waitlist mortality. However, a significant portion of patients are listed at high-priority statuses not because they meet strict clinical criteria, but through status exceptions. A recent study published in the Journal of the American College of Cardiology (JACC) by Ahn et al. suggests that this practice may be fundamentally misaligned with actual medical urgency, potentially disadvantaging the very patients the system is intended to protect.

Highlights of the Study

1. Exception recipients had a 59 percent lower risk of waitlist mortality compared to patients meeting standard clinical criteria (Hazard Ratio: 0.41).
2. The implementation of the National Heart Review Board (NHRB) in 2021 has not significantly improved the alignment between waitlist mortality risk and listing status.
3. Modeling waitlist mortality without including exceptions actually improved the system’s predictive accuracy (concordance index), suggesting that exceptions introduce noise rather than precision into the allocation process.
4. Within the highest priority category (Status 1A), there is significant heterogeneity, with exception recipients consistently showing the highest survival rates.

Background: The Challenge of Pediatric Heart Allocation

Pediatric heart transplant candidates face some of the highest waitlist mortality rates in solid organ transplantation. To manage this, the OPTN uses a tiered system (Status 1A, 1B, and 2) to categorize candidates based on their medical urgency. Status 1A is reserved for the most critically ill, such as those requiring mechanical circulatory support or high-dose inotropes.

Because pediatric heart disease is physiologically diverse—ranging from complex congenital heart disease to restrictive cardiomyopathy—standard criteria cannot always capture the nuance of every case. Consequently, transplant physicians can request status exceptions to grant a patient higher priority than their standard clinical markers would allow. While intended as a safety net for unique cases, there has been growing concern that the widespread use of exceptions leads to overcrowding at the top of the waitlist, effectively diluting the priority of candidates who meet the rigorous standard criteria.

Study Design and Methodology

To investigate the impact of these exceptions, researchers analyzed OPTN data for all pediatric heart transplant candidates listed between March 2016 and March 2025. The study cohort included 6,026 candidates. The researchers employed mixed-effects Cox proportional hazards models to estimate the association between status exceptions and waitlist mortality.

A key component of the study was the evaluation of the National Heart Review Board (NHRB). Established in 2021, the NHRB was designed to standardize the exception review process across the country, moving away from regional boards that were often criticized for inconsistency. The researchers compared outcomes before and after the NHRB implementation to see if the new board improved the alignment of status with mortality risk. Finally, they used concordance indices (C-indices) to compare the current system’s ability to predict mortality against a hypothetical system where exceptions were ignored.

Key Findings: Lower Mortality Among Exception Recipients

Among the 6,026 candidates identified, 1,668 (27.7%) received status exceptions. The results were striking: exception recipients had significantly lower waitlist mortality risk than standard criteria patients (HR: 0.41; 95% CI: 0.31-0.55; P < 0.001). This suggests that the patients being moved to the front of the line via exceptions are, on average, much healthier than the patients already waiting there under standard criteria.

Furthermore, the study found that the NHRB did not change this dynamic. The interaction between the NHRB era and the exception status was nonsignificant (P = 0.62), indicating that the national board is granting exceptions to lower-risk patients at similar rates to the previous regional systems.

The statistical analysis of the concordance index provided further evidence of systemic misalignment. The C-index for the current system was 0.694. When the researchers modeled a system without exceptions, the C-index improved to 0.713 (P < 0.001). In predictive modeling, a higher C-index indicates better performance; thus, removing exceptions actually made the status system a better predictor of who was most likely to die on the waitlist.

The NHRB: A Standardized Process Without a Standardized Outcome

The implementation of the NHRB was a major policy shift intended to bring equity to the exception process. However, the data suggests that while the process may be more standardized, the outcomes are not. The lack of improvement in the alignment of medical urgency suggests that the criteria used by the NHRB to grant exceptions may still be too broad or that the board is susceptible to the same advocacy-based pressures as regional boards.

This misalignment creates a ‘crowding out’ effect. When a large percentage of Status 1A candidates are exception recipients with lower mortality risk, the truly urgent patients—those meeting standard 1A criteria—must compete with a larger pool for the same limited number of organs. This can lead to longer wait times and higher mortality for the most critically ill children.

Expert Commentary: Advocacy vs. Equity

The findings of this study highlight a fundamental ethical dilemma in transplant medicine: the conflict between individual patient advocacy and population-level equity. Transplant physicians are naturally inclined to advocate for the highest possible priority for their patients. However, when the exception process becomes a common pathway rather than a rare necessity, it undermines the integrity of the status system.

The researchers suggest that the current ‘status-based’ system may be reaching its limits. One potential solution discussed is the move toward a ‘continuous distribution’ model, similar to what has been implemented for lung and kidney transplantation. In a continuous distribution framework, candidates are not placed in rigid boxes (1A, 1B, etc.) but are given a composite score based on multiple factors, including medical urgency, post-transplant survival probability, and biological compatibility. This would theoretically allow for a more nuanced and data-driven approach that reduces the need for binary exception requests.

Conclusion

The study by Ahn and colleagues serves as a critical call to action for the transplant community. The evidence clearly shows that pediatric heart transplant candidates granted status exceptions have significantly lower medical urgency than those meeting standard criteria. The failure of the National Heart Review Board to correct this misalignment suggests that procedural changes alone are insufficient. To ensure that the most vulnerable children receive life-saving transplants in a timely manner, the allocation system must move toward more objective, data-driven models that accurately reflect the risk of waitlist mortality without the distorting effects of the current exception process.

References

1. Ahn DJ, Attia A, Nakayama T, et al. Status Exceptions and Misalignment of Medical Urgency in U.S. Pediatric Heart Transplantation. Journal of the American College of Cardiology. 2026; doi:10.1016/j.jacc.2025.01.045.
2. Singh TP, et al. The 2018 Heart Allocation Change: Impact on Pediatric Candidates. Journal of Heart and Lung Transplantation. 2020;39(4):S156.
3. Colvin M, et al. OPTN/SRTR 2021 Annual Data Report: Heart. American Journal of Transplantation. 2023;23(2S1):S325-S412.
4. Parker WF, et al. Association of Transplant Center Request for Status Exceptions With Waitlist Outcomes. JAMA. 2019;321(11):1098-1100.